Does Dr. DARRELL BENKO have financial conflicts of interest?

Dr. DARRELL BENKO (AGPCNP-BC, PMHNP) has received a total of $652 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $652 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. DARRELL BENKO?

According to CMS Open Payments data, Dr. DARRELL BENKO received funding from AXSOME THERAPEUTICS ($145), VANDA PHARMACEUTICALS ($135), and ITI, . (D/B/A INTRA-CELLULAR THERAPIES, .) ($122).

Does Dr. DARRELL BENKO receive research grants or speaking fees?

Dr. DARRELL BENKO has received $652 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. DARRELL BENKO

AGPCNP-BC, PMHNPReal-Time Hydrated

Specialty: Nurse Practitioner, Psych/Mental Health

Practice Location: EL PASO, TX 79912

NPI Number: 1023538139

LIFETIME INDUSTRY VALUE

$652

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BENKO is a verified Nurse Practitioner, Psych/Mental Health practitioner based in EL PASO, TX.

Between 2021 and 2025, Dr. BENKO had an overall industry promotional and research financial footprint of $652 as recorded in the federal CMS Open Payments database.

$652 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BENKO's primary funding source is AXSOME THERAPEUTICS, which accounts for $145 (representing 22.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

AXSOME THERAPEUTICS

Rank 1

$145

22.3%

VANDA PHARMACEUTICALS

Rank 2

$135

20.7%

ITI, . (D/B/A INTRA-CELLULAR THERAPIES, .)

Rank 3

$122

18.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.